Revive Therapeutics Ltd C.RVV

Alternate Symbol(s): RVVTF

Healthcare

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).

CSE:RVV - Post by User

Revive Therapeutics Ltd

<< Previous

Bullboard Posts

Next >>

Post by cool888on Jul 03, 2021 9:05pm

227 Views

Post# 33490205

Few posts on Yahoo, Thx Gentlemen !

i think derrick welsh said about the most bullish thing an insider could possibly say at this stage of the game. not saying he is not blinded to the study, but still that is pretty ballsy to say just ahead of trial completion and must show a confidence in the science of bucillamine. and i don't think welsh would risk his reputation like that considering he is the science guy of the company as far as i am concerned, and the genius behind our pisolicn pharma division (psilocybin patents---unfathomable future revenue potential )

Seems to me he spoke with confidence matching what's publicly known about Bucillamine...don't see anything to indicate anything else.

Bang on !!!
Listen at around the 9:30 min mark during his interview. Derrick Wesh sounds extremely Confident.

Good Job GIFs | Tenor